Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for Retained Placenta
NCT02704780Phase 2Completed
- Sponsor
- Hawler Medical University
- Start
- Mar 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Misotac in retained placenta (2 arms), sponsored by Hawler Medical University. Primary endpoint: Delivery of placenta at 30 minutes. Started Mar 2016; status: completed.
02
Drugs
Misotac
03
Conditions
retained placenta
Beyond the preview
Go deeper on NCT02704780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704780.